Robotics for Radial Access PCI Now FDA Cleared
FDA Cleared

Robotics for Radial Access PCI Now FDA Cleared

We are happy to announce that the CorPath System has received FDA 510(k) clearance for use in PCI procedures performed via radial access. The clearance was based on the results of a 30 patient trial with 100 percent device and clinical success. Radial access is already being used broadly across the world and adoption in the United States continues to grow as patient benefits become evident. Leveraging robotics for radial PCI can reduce operator radiation exposure, which has been shown to increase during left radial manual procedures*, while enabling robotic precision and movement of standard PCI devices.

Mayo Clinic

Corindus, Mayo Clinic Partner on Launch of Robotic Program to Research Physician Safety

We recently announced the launch of a CorPath Vascular Robotic Program at Mayo Clinic, a leading healthcare institution in the nation. The partnership between Corindus and Mayo Clinic will include collaborative research projects to enhance the use of robotic technology to improve patient care as well as provider safety. This collaboration is an important step toward accelerating the progress currently being made by robotic technology in the cardiology field.


TCTMD: Robotic Systems to Play Greater Role in Cath Lab of the Future

In a recent article on TCTMD, the author notes that the introduction of robotic systems into the cath lab, accompanied by their integration with other technologies, is expected to benefit both patients and physicians, as presented during a session devoted to innovation at TCT 2015. The piece notes that while the initial clinical trial to gain FDA 510(k) clearance for the CorPath System focused mainly on simple lesions, the system is currently being used in practice for more complex PCI procedures including bifurcation lesions, total occlusions, and high-risk PCI requiring support with the Impella® system.

TCT 2015

TCT 2015 Highlights New Technologies for Complex PCI

The Corindus team is back to our office in Waltham after another successful Transcatheter Cardiovascular Therapeutics (TCT) conference under our belt! TCT is one of the most important conferences of the year in Interventional Cardiology and attracted key opinion leaders and physicians from across the world and US specifically. During the meeting, CorPath was highlighted during several featured presentations and multiple abstracts on complex and radial PCI performed robotically. In addition, attendees were able to test drive the system in a simulated complex PCI in our booth.

Complex Robotic PCI of the Month

Complex Robotic PCI of the Month

On a monthly basis, we will be featuring a complex robotic PCI case performed by a CorPath user. If you are interested in being featured for an interesting procedure performed using CorPath, please contact your Clinical Account Manager.

CorPath PCI of Total Occlusion and Triple Vessel Disease

During this intervention, Dr. Michael Ragosta was able to easily integrate multiple devices with the CorPath System. The system provided enhanced visualization to facilitate successful, precise stent manipulation and reduced radiation exposure to the operator who performed the procedure from a seated position.

For more information on CorPath email:
Copyright Corindus, Inc.
309 Waverley Oaks Road, Suite 105, Waltham, MA 02452, US
Corporate Office: 508-653-3335 | Sales & Customer Service: 800-605-9635 | Fax: 508-232-6000 | Contact us

* Pancholy SB, Joshi P, Shah S, et al. Randomized evaluation of vascular entry site and radiation exposure: the REVERE trial. J Am Coll Cardiol Intv. 2015; Epub ahead of print.